NGAL is a biomarker of tubular injury, is expressed in several histotypes of renal tumors and its high expression is associated with a higher histological grade of ccRCC and papillary RCC, whereas oncocytoma and urothelial carcinoma exhibit lower expression levels (17). The gene discussed is LCN2; the disease is urothelial carcinoma.